NCT00053781 2023-08-04
Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Canadian Cancer Trials Group
Phase 2 Completed
Clinical Trials
19 trialsNCT00053794 2023-08-04
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Canadian Cancer Trials Group
Phase 2 Completed
NCT00590954 2020-10-19
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00398710 2018-03-15
A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia
AEterna Zentaris
Phase 2 Completed
NCT00391560 2018-03-14
Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia
AEterna Zentaris
Phase 2 Completed
NCT00398879 2018-03-14
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
AEterna Zentaris
Phase 2 Completed
NCT00389077 2018-03-07
Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas
AEterna Zentaris
Phase 2 Completed
NCT00401388 2018-03-07
A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
AEterna Zentaris
Phase 2 Completed
NCT00448721 2018-03-01
A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer
AEterna Zentaris
Phase 2 Completed
NCT00375791 2018-02-28
Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma
AEterna Zentaris
Phase 2 Completed
NCT00455559 2018-02-22
Ph II Study of Perifosine Plus Gleevec for Patients With GIST
AEterna Zentaris
Phase 2 Completed
NCT00498966 2018-02-05
Ph II Study of Perifosine for Patients With Carcinoma of the Kidney
AEterna Zentaris
Phase 2 Completed
NCT00422656 2017-12-26
Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00053924 2015-07-23
Perifosine in Treating Patients With Advanced Pancreatic Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00054145 2015-07-23
Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00059982 2013-06-24
Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00060437 2013-06-19
Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00064324 2013-06-04
Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00873457 2013-05-27
Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Duke University
Phase 2 Completed